Treatment-Resources-for-Providers COVID-19 Treatment Resources for Healthcare Providers

COVID-19 Treatment Resources for Healthcare Providers


Dr explaining prescription to patient 

There are now multiple products approved by the U.S. Food and Drug Administration (FDA) for the outpatient treatment and authorized for the prevention of COVID-19.  The primary goal of these medications is to reduce hospitalizations and deaths in high-risk patients with COVID-19.  

Providers should have a low threshold to prescribe COVID-19 therapeutics given the broad range of individuals who are at higher risk for severe COVID-19 and can benefit from COVID-19 treatment. 

Please refer to this page and associated links for the latest guidance and resources on COVID-19 therapeutics.​​  


Overview of Antivirals 

Effective treatment for outpatients with mild-to-moderate COVID-19 is available and should be offered to all eligiblepatients.  

The FDA has approved the following medications for treatment of COVID-19: Coronavirus (COVID-19) | Drugs | FDA 

CDC MMWR COVID-19 Antivirals Diagram.png

Originally published on June 15, 2022